期刊文献+

中西医结合治疗糖尿病肾病60例疗效观察 被引量:5

Influence of Combine Traditional Chinese and Western Medicine Treatment for Diabetic Nephropathy
下载PDF
导出
摘要 目的:观察中西医结合治疗糖尿病肾病的临床疗效。方法:将120例糖尿病肾病患者随机分为两组,对照组60例,常规用口服降糖药糖适平或胰岛素治疗+ACEI类药卡托普利片(开博通)治疗。治疗组60例,在对照组基础上进行中医辨证施治。两组以8周为一个疗程。治疗前后进行临床症状、24小时尿蛋白定量、尿蛋白排泻率(UAER)、空腹血糖(FBG)、餐后2小时血糖(2hPBG)、糖化血红蛋白(HAb1C)、尿素氮(BUN)、血肌肝(SCr)、总胆固醇(TC)、甘油三脂(TG)及血液流变学等项目观察。结果:治疗组显效15例,有效38例,无效8例,总有效率88.3%。对照组显效6例,有效29例,无效24例,总有效率58.3%。两组比较,差异有显著性意义(P<0.0.5)。结论:中西医结合治疗糖尿病肾病,临床疗效显著。 Objective:To observe the clinical curative effect on combine Chinese traditional and Western medicine treatment for Diabetic Nephropathy(DN).Methods:Randomly divide 120 patients of DN into 2 groups.Each group has 60 cases,the control group take the medicine Glurenorm or inject the drug Insuline and take ACEI drug as Capoten.The treatment group,on the base of the control group,accept combine traditional Chinese and Western medicine treatment.Both of the 2 groups take 8 weeks as a course of treatment.Before the treatment,all the patients of the two groups go on with the clinic surreys of the items like MA,UAER,FBG,2hPBG,HbA1c,Bun,Scr,TC,TG and hemorheology etc.Results:In the treatment group,15 cases has obvious effects,38 cases are effective,8 cases are invalid,the total effective rate is 88.3%.In the control group,6 cases has obvious effects,29 cases are effective,24 cases are invalid,the total effective rate is 58.3%.To compare with the 2 groups,the difference is significant(P0.05).Conclusion:After combine traditional Chinese and Western medicine treatment,the clinical curative effect is significant.
作者 陈斌
出处 《中国医药导刊》 2012年第3期390-391,393,共3页 Chinese Journal of Medicinal Guide
关键词 中西医结合疗法 糖尿病肾病 中医辨证施治 Combine traditional Chinese and western medicine treatment Diabetic Nephropathy Diagnosic and treatment based on an overall analysis of the illness and the patient’s condition
  • 相关文献

参考文献10

二级参考文献46

  • 1杨彩霞.中西医结合治疗糖尿病肾病50例[J].中国中医药现代远程教育,2009(2):20-20. 被引量:3
  • 2林善锬.糖尿病肾病[J].中华内科杂志,2005,44(3):229-231. 被引量:117
  • 3程苏琴,朱美财.尿微量白蛋白在糖尿病肾损伤早期诊断中的价值[J].中华检验医学杂志,2005,28(7):740-741. 被引量:203
  • 4Adler A I,Stevens R J,Manley S E,et al.Development and progression of nephropathy in type 2 diabetes:the United Kingdom Prospective Diabetes Study(UKPDS 64)[J].Kidneyt Int,2003,63(1):225-232. 被引量:1
  • 5Brenner B M,Cooper M E,de Zeeuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J].N Engl J Med,2001,345(12):861-869. 被引量:1
  • 6Chan J C,Wat N M,So W Y,et al.Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes.An Asian perspective from the RENAAL study[J].Dabetes Care,2004,27(4):874-879. 被引量:1
  • 7The ADVANCE Collaborative Group.Intesive biood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358(24):2 560-2 572. 被引量:1
  • 8郑筱萸.中药新药治疗消渴病(糖尿病)的临床研究指导原则[M].北京:中国中医药科技出版社,2002,232-234. 被引量:2
  • 9Report of a WHO consultation.Definition,diagnosis and classification of diabetesmellitus and its complication[S] Geneva:World Health Organization,1999.53. 被引量:1
  • 10邓尚平.糖尿病防治知识讲座,1999,5:73. 被引量:1

共引文献30

同被引文献32

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部